XML 90 R77.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information - Schedule of Business Segments (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Segment Reporting Information [Line Items]          
Net sales $ 2,419 $ 2,648 $ 7,340 $ 7,910  
Cost of sales (1,898) (2,029) (5,811) (6,100)  
Gross profit 521 619 1,529 1,810  
Selling, general and administrative expenses (231) (248) (676) (770)  
Amortization (42) (40) (124) (119)  
Research and development expenses (31) (32) (93) (99)  
Other (charges) gains, net (Note 18) (1,491) (61) (1,542) (123)  
Gain (loss) on disposition of business and assets, net (3) (3) (2) (12)  
Other segment items(2) 2 [1] 10 [1] 29 [2] 12 [2]  
Operating profit (loss) (1,275) 245 (879) 699  
Depreciation and amortization 194 203 564 616  
Equity in net earnings (loss) of affiliates 39 51 90 157  
Capital expenditures 73 [3] 99 [3] 235 [4] 291 [4]  
Goodwill and intangible assets, net 7,383   7,383   $ 9,028
Total assets 22,169   22,169   22,838
Increase (decrease) in accrued capital expenditures 9 11 (24) (39)  
Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 1,384 1,481 4,113 4,326  
Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales [5] 1,035 1,167 3,227 3,584  
Operating Segments | Engineered Materials          
Segment Reporting Information [Line Items]          
Net sales 1,384 1,481 4,113 4,326  
Cost of sales (1,052) (1,147) (3,163) (3,369)  
Gross profit 332 334 950 957  
Selling, general and administrative expenses (105) (110) (313) (322)  
Amortization (42) (40) (123) (118)  
Research and development expenses (20) (22) (62) (70)  
Other (charges) gains, net (Note 18) (1,490) (60) (1,521) (114)  
Gain (loss) on disposition of business and assets, net (2) (2) 0 (9)  
Other segment items(2) 0 [2] 0 [1] 0 [2] 0 [2]  
Operating profit (loss) (1,327) 100 (1,069) 324  
Depreciation and amortization 118 127 341 395  
Equity in net earnings (loss) of affiliates 33 44 73 140  
Capital expenditures 35 59 120 137  
Goodwill and intangible assets, net 6,945   6,945   8,617
Total assets 14,221   14,221   15,485
Operating Segments | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales 1,061 1,190 3,292 3,653  
Cost of sales (876) (910) (2,716) (2,796)  
Gross profit 185 280 576 857  
Selling, general and administrative expenses (38) (32) (89) (92)  
Amortization 0 0 (1) (1)  
Research and development expenses (11) (10) (31) (30)  
Other (charges) gains, net (Note 18) 0 1 (4) 0  
Gain (loss) on disposition of business and assets, net (1) (1) (2) (3)  
Other segment items(2) 0 [2] 0 [1] 0 [2] 0 [2]  
Operating profit (loss) 135 238 449 731  
Depreciation and amortization 63 63 188 181  
Equity in net earnings (loss) of affiliates 3 2 8 7  
Capital expenditures 32 33 94 109  
Goodwill and intangible assets, net 438   438   411
Total assets 5,413   5,413   5,257
Segment Reporting, Reconciling Item, Corporate Nonsegment | Corporate Segment and Other Operating Segment [Member]          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 0  
Cost of sales 4 5 3 (4)  
Gross profit 4 5 3 (4)  
Selling, general and administrative expenses (88) (106) (274) (356)  
Amortization 0 0 0 0  
Research and development expenses 0 0 0 1  
Other (charges) gains, net (Note 18) (1) (2) (17) (9)  
Gain (loss) on disposition of business and assets, net 0 0 0 0  
Other segment items(2) 2 [1] 10 [1] 29 [2] 12 [2]  
Operating profit (loss) (83) (93) (259) (356)  
Depreciation and amortization 13 13 35 40  
Equity in net earnings (loss) of affiliates 3 5 9 10  
Capital expenditures 6 7 21 45  
Goodwill and intangible assets, net 0   0   0
Total assets 2,535   2,535   2,096
Eliminations          
Segment Reporting Information [Line Items]          
Net sales (26) [6] (23) [6] (65) [7] (69) [7]  
Cost of sales 26 23 65 69  
Gross profit 0 0 0 0  
Selling, general and administrative expenses 0 0 0 0  
Amortization 0 0 0 0  
Research and development expenses 0 0 0 0  
Other (charges) gains, net (Note 18) 0 0 0 0  
Gain (loss) on disposition of business and assets, net 0 0 0 0  
Other segment items(2) 0 [1] 0 [1] 0 [2] 0 [2]  
Operating profit (loss) 0 0 0 0  
Depreciation and amortization 0 0 0 0  
Equity in net earnings (loss) of affiliates 0 0 0 0  
Capital expenditures 0 0 0 0  
Goodwill and intangible assets, net 0   0   0
Total assets 0   0   $ 0
Eliminations | Acetyl Chain          
Segment Reporting Information [Line Items]          
Net sales $ 26 $ 23 $ 65 $ 69  
[1] Includes Foreign exchange gain (loss), net.
[2] Includes Foreign exchange gain (loss), net.
[3] Includes an increase in accrued capital expenditures of $9 million and $11 million for the three months ended September 30, 2025 and 2024, respectively.
[4] Includes a decrease in accrued capital expenditures of $24 million and $39 million for the nine months ended September 30, 2025 and 2024, respectively.
[5] Excludes intersegment sales of $26 million and $23 million for the three months ended September 30, 2025 and 2024, respectively. Excludes intersegment sales of $65 million and $69 million for the nine months ended September 30, 2025 and 2024, respectively.
[6] Includes intersegment sales primarily related to the Acetyl Chain.
[7] Includes intersegment sales primarily related to the Acetyl Chain.